Ablation of asymptomatic accessory pathways: is it really necessary?
Congress : EHRA 2017
- Topic : arrhythmias and device therapy
- Sub-topic : Catheter Ablation of Arrhythmias
- Session type : Symposium
- FP Number : 1328
Members get moreJoin now
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.